175 related articles for article (PubMed ID: 10607234)
1. Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-alpha therapy in patients with chronic hepatitis B.
Fei GZ; Sylvan SP; Yao GB; Hellström UB
J Viral Hepat; 1999 May; 6(3):219-27. PubMed ID: 10607234
[TBL] [Abstract][Full Text] [Related]
2. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.
You J; Sriplung H; Geater A; Chongsuvivatwong V; Zhuang L; Li YL; Lei H; Liu J; Chen HY; Tang BZ; Huang JH
BMC Infect Dis; 2008 Sep; 8():123. PubMed ID: 18803883
[TBL] [Abstract][Full Text] [Related]
3. Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B.
You J; Sriplung H; Geater A; Chongsuvivatwong V; Zhuang L; Chen HY; Yu L; Tang BZ; Huang JH
World J Gastroenterol; 2008 Feb; 14(7):1112-9. PubMed ID: 18286696
[TBL] [Abstract][Full Text] [Related]
4. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir.
Arasli M; Ustundag Y; Delikanli B; Harmandar F; Buyukuysal C
Hepatogastroenterology; 2012 May; 59(115):851-7. PubMed ID: 22193343
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin and IFN-alpha combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B.
Ren FY; Jin H; Piao XX; Piao FS
World J Gastroenterol; 2007 Nov; 13(41):5440-5. PubMed ID: 17907286
[TBL] [Abstract][Full Text] [Related]
7. T cell subsets in chronic hepatitis B and the effect of prednisolone withdrawal and interferon alpha-2b.
Im EH; Lee BS; Sung JK; Lee SO; Lee KT; Lee SM; Kim SH; Seo KS; Kim JH; Kim SG; Kim NJ; Lee HY
Korean J Intern Med; 1999 Jan; 14(1):1-8. PubMed ID: 10063307
[TBL] [Abstract][Full Text] [Related]
8. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients.
Liu YZ; Hou FQ; Ding P; Ren YY; Li SH; Wang GQ
Virol J; 2012 Nov; 9():274. PubMed ID: 23158844
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus DNA is more powerful than HBeAg in predicting peripheral T-lymphocyte subpopulations in chronic HBV-infected individuals with normal liver function tests.
You J; Sriplung H; Geater A; Chongsuvivatwong V; Zhuang L; Chen HY; Huang JH; Tang BZ
World J Gastroenterol; 2008 Jun; 14(23):3710-8. PubMed ID: 18595137
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T
J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients.
Guptan RC; Thakur V; Kazim SN; Sarin SK
J Gastroenterol Hepatol; 2002 Jul; 17(7):765-71. PubMed ID: 12121506
[TBL] [Abstract][Full Text] [Related]
12. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
[TBL] [Abstract][Full Text] [Related]
13. Decreased ratio of CD4/CD8 lymphocytes might be predictive for successful interferon alpha and lamivudine combined therapy in childhood chronic hepatitis B infection: A preliminary study.
Genel F; Unal F; Ozgenc F; Aksu G; Aydogdu S; Kutukculer N; Yagci RV
J Gastroenterol Hepatol; 2003 Jun; 18(6):645-50. PubMed ID: 12753145
[TBL] [Abstract][Full Text] [Related]
14. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
[TBL] [Abstract][Full Text] [Related]
15. The impact of HBV-DNA fluctuations on virus-specific CD8+ T cells in HBeAg+ chronic hepatitis B patients treated with a steroid and lamivudine.
Gotto J; Webster GJ; Brown D; Jenkins J; Dusheiko GM; Bertoletti A
J Viral Hepat; 2006 Jun; 13(6):415-25. PubMed ID: 16842445
[TBL] [Abstract][Full Text] [Related]
16. Immune Cell Subsets Evaluation as a Predictive Tool for Hepatitis B Infection Outcome and Treatment Responsiveness.
Kandilarova SM; Georgieva AI; Mihaylova AP; Baleva MP; Atanasova VK; Petrova DV; Popov GT; Naumova EJ
Folia Med (Plovdiv); 2017 Mar; 59(1):53-62. PubMed ID: 28384114
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
[TBL] [Abstract][Full Text] [Related]
18. [Identification of circulating type II pre-dendritic cells (pDC2) and its clinical significance in chronic hepatitis B virus infection].
Xing LH; Ma WP; Zhang XS; Shao XW; Ding XL; Peng JY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):247-9. PubMed ID: 17971935
[TBL] [Abstract][Full Text] [Related]
19. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
[TBL] [Abstract][Full Text] [Related]
20. Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
ter Borg MJ; Hansen BE; Herrmann E; Zeuzem S; Cakaloglu Y; Karayalcin S; Flisiak R; van' t Veen A; de Man RA; Schalm SW; Janssen HL; Haagmans BL;
Antivir Ther; 2007; 12(8):1285-94. PubMed ID: 18240868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
